Rabasseda X
Thomson Reuters, Barcelona, Spain.
Drugs Today (Barc). 2014 Nov;50(11):763-74. doi: 10.1358/dot.2014.50.11.2256386.
The first waves of winter cold were sweeping across Massachusetts at the time this year's American Academy for the Study of Liver Diseases' Liver Meeting opened gates to a crowd of scientists and researchers from across the globe. The Hynes Convention Center acted as the liver through which new research from many different sources, shaped as oral and poster presentations, was transformed into a story of hope for new, more effective treatments for common liver diseases, particularly viral hepatitis infection and nonalcoholic steatohepatitis. As summarized in the following report, novel research was also reported emphasizing novel potential therapies for liver cancer as well as a broad range of liver diseases.
今年美国肝病研究学会肝脏会议召开之时，冬季的第一波寒潮正席卷马萨诸塞州。来自全球各地的科学家和研究人员齐聚海因斯会议中心，这里就像肝脏一样，众多不同来源的新研究以口头报告和海报展示的形式呈现出来，转化为对常见肝病，尤其是病毒性肝炎感染和非酒精性脂肪性肝炎的新的、更有效治疗方法的希望故事。如下文报告总结，还报道了强调肝癌以及广泛肝病新潜在疗法的新颖研究。
